Results 151 to 160 of about 9,755 (173)

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Nature Reviews Drug Discovery, 2021
Thomas Bieber
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

RAS-targeted therapies: is the undruggable drugged?

Nature Reviews Drug Discovery, 2020
Amanda R Moore, Frank McCormick, Shiva Malek   +2 more
exaly  

[Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].

, 2012
Shingo Morinaga, Y. Ide, Masaru Kusumoto, Mika Ogata, Kazutaka Takaki, Emiko Matsumoto   +5 more
openalex  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

B cell depletion therapies in autoimmune disease: advances and mechanistic insights

Nature Reviews Drug Discovery, 2020
Olga L Rojas, Jennifer L Gommerman
exaly